Overview
- Unique focus on users of CER
- Insights from industry decision makers paired with practitioner thought leaders
- Cutting edge technology applied to fundamental industry/policy challenges
- Assesses promise and realities of CER: past and future
- Considers both US and ex-US contexts
Access this book
Tax calculation will be finalised at checkout
Other ways to access
Table of contents (21 chapters)
-
Front Matter
-
The Future of Comparative Effectiveness Research for Evidence Developers: Perspectives from Pharmaceutical Decision Makers
-
Front Matter
-
-
Evolving Stakeholder Considerations: Patients, Physicians, Regulators and Payers
-
Front Matter
-
Keywords
About this book
Reviews
Editors and Affiliations
About the editors
Dr. Birnbaum is a Principal at Analysis Group. Dr. Birnbaum’s professional interest is performing economic investigations regarding the comparative effectiveness and value of medical services and products and health economics of specific conditions using real world data from administrative claims files, medical records, and surveys of patients and physicians, as well as clinical trial data. He has conducted health economics and outcomes research across a broad range of physical and mental disorders for pharmaceutical and biotechnology manufacturers, managed care organizations, and government agencies, as well as provided expert testimony and litigation support in matters regarding Medicare and Medicaid reimbursement and managed care issues. Dr. Birnbaum has published numerous articles in leading medical, health economics, and managed care journals on a wide range of conditions. Dr. Birnbaum also serves on the editorial board of PharmacoEconomics, and is a member of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Institutional Council.
Mr. Greenberg is the Director of Analysis Group's Health Care Practice and specializes in health economics, both in health outcomes research and in complex business litigation. He consults to pharmaceutical, biotechnology, and medical device companies concerning the health economics profiles of specific diseases and medical products. Mr. Greenberg has overseen cost-of-illness research relating to numerous physical and psychiatric disorders, as well as pharmacoeconomic assessments of the cost-effectiveness of drugs based on data gathered in clinical trials and administrative claims files. Mr. Greenberg also draws upon the methodological tools and data sources used in health outcomes research to analyze problems that emerge in litigation. He currently serves on the editorial boards of PharmacoEconomics, Journal of Medical Economics, and Expert Opinion on Pharmacotherapy.
Bibliographic Information
Book Title: Decision Making in a World of Comparative Effectiveness Research
Book Subtitle: A Practical Guide
Editors: Howard G. Birnbaum, Paul E. Greenberg
DOI: https://doi.org/10.1007/978-981-10-3262-2
Publisher: Adis Singapore
eBook Packages: Medicine, Medicine (R0)
Copyright Information: Springer Nature Singapore Pte Ltd. 2017
Hardcover ISBN: 978-981-10-3261-5Published: 12 May 2017
Softcover ISBN: 978-981-10-9828-4Published: 29 July 2018
eBook ISBN: 978-981-10-3262-2Published: 05 May 2017
Edition Number: 1
Number of Pages: XVI, 289
Number of Illustrations: 11 b/w illustrations, 7 illustrations in colour
Topics: Pharmacoeconomics and Health Outcomes, Health Economics, Statistics for Life Sciences, Medicine, Health Sciences, Pharmaceutical Sciences/Technology